Skip to main content
Mitchell Elkind, MD, Neurology, New York, NY

Mitchell S. Elkind MD

Spinal Disorder, Vascular Neurology


Columbia University

Join to View Full Profile
  • 710 W 168th StNew York, NY 10032

  • Phone+1 212-305-1710

  • Fax+1 212-305-1658

Dr. Elkind is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1993 - 1996
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1992 - 1993
  • Harvard Medical School
    Harvard Medical SchoolClass of 1992

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1996 - 2026
  • CT State Medical License
    CT State Medical License 2007 - 2025
  • NJ State Medical License
    NJ State Medical License 2007 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Vascular Neurology
    American Board of Psychiatry and Neurology Vascular Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2014
  • Top Doctors: New York Metro Area Castle Connolly, 2014
  • New York Magazine: Top Doctors Castle Connolly, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Inequities in Heart Health Found by Race, Gender
    Inequities in Heart Health Found by Race, GenderFebruary 3rd, 2025
  • Long-Term Cognitive Monitoring Warranted After First Stroke
    Long-Term Cognitive Monitoring Warranted After First StrokeOctober 11th, 2024
  • Anticoagulation Uncertainty in Embolic Stroke of Undetermined Source
    Anticoagulation Uncertainty in Embolic Stroke of Undetermined SourceSeptember 20th, 2024
  • Join now to see all

Grant Support

  • FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
  • FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
  • FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
  • FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2030
  • Neurology Research Education And Mentorship ProgramNational Institute Of Neurological Disorders And Stroke2010–2012
  • Stroke Incidence And Risk Factors In A Tri-Ethnic RegionNational Institute Of Neurological Disorders And Stroke2008–2012
  • Neuroprotection With Statin Therapy For Acute Recovery Trial (NEUSTART)National Institute Of Neurological Disorders And Stroke2010–2011
  • Neuroprotection With Statin Therapy For Acute Stroke-Recovery TrialNational Institute Of Neurological Disorders And Stroke2007–2008
  • Levels Of Inflammatory Markers In Treatment Of StrokeNational Institute Of Neurological Disorders And Stroke2005–2008
  • Inflammatory And Infectious Burden And Risk Of StrokeNational Institute Of Neurological Disorders And Stroke2004–2008
  • Neuroprotection With Statin Therapy For Acute StrokeNational Institute Of Neurological Disorders And Stroke2004–2006
  • Inflammation And Infection As Risk Factors In StrokeNational Institute Of Neurological Disorders And Stroke2002–2006
  • Hu23f2g In Patients With Acute Ischemic StrokeNational Center For Research Resources2000–2002

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: